Conference Coverage
Conference Coverage
Cardiopathy no basis for choosing anticoagulation in ESUS
“It could be that this concept of thrombogenic atrial cardiopathy really isn’t present unless there is also atrial fibrillation.”
Conference Coverage
No added benefit from revascularization in low-risk CAS
“We are more aware of how we should treat” these patients, and “we’re probably a bit more aggressive,” which will have shifted the outcomes in the...
Conference Coverage
Standard measure may underestimate OSA in Black patients
Measurement error may be the culprit in underdiagnosing obstructive sleep apnea in Black patients.
Conference Coverage
Care bundle improves outcome in ICH: INTERACT3
“This is a groundbreaking result. It is the first-ever published trial in ICH patients to show a clear benefit on functional outcomes and on...
Conference Coverage
Earlier anticoagulation safe in stroke with AFib: ELAN
“This trial will change clinical practice in that we can feel much more reassured that starting DOAC treatment early in these patients will not...
Conference Coverage
Stroke scale cutoff might not be ideal guide for ordering CTA and detecting large vessel occlusions
If the goal is not to miss any LVOs, there is no NIHSS score below which these do not occur.
Conference Coverage
Teriflunomide delays MS symptoms in radiologically isolated syndrome
The data support the theory that treatment should begin early in patients with a high likelihood of developing symptomatic MS on the basis of...
Conference Coverage
Novel levodopa delivery system promises continuous dosing without surgery or pump
The experimental device is designed to deliver levodopa and carbidopa into the mouth through a micropump within a wearable retainer.
Conference Coverage
U.S. incidence, prevalence of myasthenia gravis is rising
These new estimates are “significantly higher” than those from a prior U.S. analysis from 2003.
Conference Coverage
Head-to-head comparison of migraine meds reveals top options
“To the best of our knowledge, this is the first study that simultaneously compared multiple acute migraine medications using a Big Data analysis...
Conference Coverage
Oral antiamyloid shows disease-modifying potential Phase 3 trial underway
Phase 2 data showed that use of the drug resulted in positive changes in plasma and imaging biomarkers of Alzheimer’s disease pathology.